Ciclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Trial Profile

Ciclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 18 Mar 2016

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Multiple organ failure; Myocardial infarction; Reperfusion injury
  • Focus Therapeutic Use
  • Acronyms CLOTILDE
  • Most Recent Events

    • 15 Mar 2016 Status changed from not yet recruiting to withdrawn prior to enrolment, according to ClinicalTrials.gov record.
    • 28 May 2014 Planned End Date changed from 1 Jan 2016 to 1 Oct 2015, according to ClinicalTrials.gov record.
    • 13 Nov 2013 Planned End Date changed from 1 Sep 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top